AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 280: F636-F645, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laouari, D.
Right arrow Articles by Friedlander, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laouari, D.
Right arrow Articles by Friedlander, G.
Vol. 280, Issue 4, F636-F645, April 2001

Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure

Denise Laouari1, Ruchun Yang1, Celine Veau2, Isabelle Blanke1, and Gérard Friedlander1

1 Institut National de la Santé et de la Recherche MédicaleU-426 and Institut Federatif de Recherche "Cellules Epithéliales," Faculté Xavier Bichat, 75018 Paris; and 2 Unité Propre de Recherche et Enseignement Superieur 2706, Faculté de Pharmacie, 92290 Chatenay-Malabry, France

Tubular function is altered in chronic renal failure (CRF). Whether drug secretion by renal tubules is modified in CRF is questioned because of frequent accumulation of various toxins in CRF. This function mainly involves ATP-dependent drug transporters, particularly P-glycoprotein (P-gp) and multidrug resistance-associated protein (MRP) 2, both present in apical membrane of epithelial cells. The present study was aimed at determining the changes in P-gp and MRP2 expression induced by experimental CRF in kidney and liver. The relationship between MRP2 and glutathione metabolism changes was examined because MRP2 transports GSSG and glutathione conjugates. Rats underwent either 80% subtotal nephrectomy (Nx) or sham operation, and determinations were performed 3 and 6 wk later. CRF induced a 70-200% rise in protein and mRNA expression of MRP2 after 3 and 6 wk post-Nx in remnant kidney and after 6 wk in liver. However, P-gp expression was unchanged by CRF. Relative to whole kidney mass, total MRP2 levels decreased by only 27% in Nx rats whereas total P-gp levels were reduced by 60%. Renal GSSG and total glutathione levels were increased by 30% in Nx rats, but glutathione-S-transferase (GST) activity was normal; liver GSSG levels and GST activity were reduced in Nx rats. In conclusion, CRF resulted in specific overexpression of MRP2 in kidney and liver. This could be an adaptative response to some elevated circulating toxins. The later MRP2 induction and different glutathione changes in liver compared with kidney suggest different mechanisms for MRP2 induction and/or action in these two tissues.

tubular function; uremia; rat; drug excretion; P-glycoprotein; multidrug resistance-associated protein 2


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. Huls, F. G. M. Russel, and R. Masereeuw
The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 3 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Lu and C. Klaassen
Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats
Drug Metab. Dispos., January 1, 2008; 36(1): 16 - 23.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Naud, J. Michaud, F. A. Leblond, S. Lefrancois, A. Bonnardeaux, and V. Pichette
Effects of Chronic Renal Failure on Liver Drug Transporters
Drug Metab. Dispos., January 1, 2008; 36(1): 124 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
G. Tramonti, P. Xie, E. I. Wallner, F. R. Danesh, and Y. S. Kanwar
Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes.
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F972 - F980.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ledoux, R. Yang, G. Friedlander, and D. Laouari
Glucose Depletion Enhances P-Glycoprotein Expression in Hepatoma Cells: Role of Endoplasmic Reticulum Stress Response
Cancer Res., November 1, 2003; 63(21): 7284 - 7290.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. M. Gerk and M. Vore
Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 407 - 415.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. A. Terlouw, C. Graeff, P. H. E. Smeets, G. Fricker, F. G. M. Russel, R. Masereeuw, and D. S. Miller
Short- and Long-Term Influences of Heavy Metals on Anionic Drug Efflux from Renal Proximal Tubule
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 578 - 585.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Veau, C. Leroy, H. Banide, D. Auchere, S. Tardivel, R. Farinotti, and B. Lacour
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion
Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1607 - 1614.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online